Irish Consortium to Develop Novel Treatment for ARDS Caused by COVID19
An Irish consortium involving NUI Galway, OmniSpirant Limited, a start-up biotechnology company and Aerogen Limited, has been awarded €11.6 million under the Di...
Disruptive Technologies Innovation Fund
